Debbie Marriott
- Virology top 5%
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 5
- Antifungal resistance and susceptibility 5
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 6
- Drug-Induced Adverse Reactions 3
- Molecular Medicine top 5%
-
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Fungal Infections and Studies 4
- Mycobacterium research and diagnosis 3
-
- Syphilis Diagnosis and Treatment 3
- Co-authors
- Indy SandaraduraSahand ImaniSheridan GentiliHergen BuscherSebastiaan J. van HalJanaki AminD. StarkJohn Ellis
- Journals
- The Medical Journal of Australia (5 papers)Journal of Antimicrobial Chemotherapy (3 papers)Immunity (2 papers)
- Partner nations
- AustraliaUnited StatesChina
In The Last Decade
Debbie Marriott
36 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Applied Microbiology and Biotechnology 78
- Virology 160
- Infectious Diseases 572
- Pharmacology 404
- Molecular Medicine 85
Countries citing papers authored by Debbie Marriott
This map shows the geographic impact of Debbie Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debbie Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debbie Marriott more than expected).
Fields of papers citing papers by Debbie Marriott
This network shows the impact of papers produced by Debbie Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debbie Marriott. The network helps show where Debbie Marriott may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Debbie Marriott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 18 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 29 | |
| 6 | 2020 | 45 | |
| 7 | 2019 | 9 | |
| 8 | 2018 | 23 | |
| 9 | 2017 | 33 | |
| 10 | 2017 | 204 | |
| 11 | 2012 | 31 | |
| 12 | 2012 | 86 | |
| 13 | 2009 | 99 | |
| 14 | 2009 | 2 | |
| 15 | 2008 | 1 | |
| 16 | 2008 | 248 | |
| 17 | 2006 | 17 | |
| 18 | 2005 | 46 | |
| 19 | 2005 | 42 | |
| 20 | 1995 | 17 |
About Debbie Marriott
Debbie Marriott is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Epidemiology, Pharmacology and Endocrinology, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), HIV/AIDS drug development and treatment (5 papers), Antifungal resistance and susceptibility (5 papers), Fungal Infections and Studies (4 papers), Drug-Induced Adverse Reactions (3 papers), Syphilis Diagnosis and Treatment (3 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (78 citations), Virology (160 citations), Infectious Diseases (572 citations), Pharmacology (404 citations) and Molecular Medicine (85 citations). Debbie Marriott has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Indy Sandaradura, Sahand Imani, Sheridan Gentili, Hergen Buscher, Sebastiaan J. van Hal, Janaki Amin, D. Stark, John Ellis, Andrew Carr and John E. Ray. Their work appears in journals such as The Medical Journal of Australia, Journal of Antimicrobial Chemotherapy, Immunity, Journal of Clinical Microbiology and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.